Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Urologiia ; (5): 80-4, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-17444158

RESUMEN

The experiments on 45 rats and 20 rabbits were made to investigate antiischemic efficacy of alpha-tocopherol in respect of various partial functions of the kidneys compared to its antioxidant activity. It is demonstrated that administration of alpha-tocopherol prior to 30-min heat ischemia arrests activation of membrane lipid peroxidation (LPO) in the tissue of ischemic kidney both in rabbits and rats. Rabbit filtration renal function 1 hour after circulation recovery improved insignificantly, 24 hours after the recovery no difference with the control was registered, while secretory and reabsorption functions of the renal tubules under conditions of pretreatment with alpha-tocopherol significantly improved both in rabbits and rats both 1 hour and 24 hours after ischemia. Estimation of Ca-ATP activity of a microsomal fraction of the cortical substance of the ischemic kidneys has detected alpha-tocopherol induced suppression of LPO in sub-cellular membrane and high activity of this enzyme. Mechanisms of different protective action of alpha-tocopherol on renal glomeruli and tubules are discussed.


Asunto(s)
Antioxidantes/uso terapéutico , Tasa de Filtración Glomerular/efectos de los fármacos , Isquemia/tratamiento farmacológico , Capacidad de Concentración Renal/efectos de los fármacos , Riñón/irrigación sanguínea , alfa-Tocoferol/uso terapéutico , Animales , Antioxidantes/administración & dosificación , Calcio/orina , Creatinina/sangre , Creatinina/orina , Modelos Animales de Enfermedad , Radioisótopos de Yodo , Ácido Yodohipúrico , Isquemia/fisiopatología , Isquemia/orina , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/fisiopatología , Peróxidos Lipídicos/metabolismo , Conejos , Renografía por Radioisótopo , Ratas , Sodio/orina , alfa-Tocoferol/administración & dosificación
4.
Urol Nefrol (Mosk) ; (5): 5-9, 1997.
Artículo en Ruso | MEDLINE | ID: mdl-9412018

RESUMEN

The author studied the effects of 30-min heat ischemia of rat kidneys on the level of malonic dialdehyde (MDA) and Ca-dependent ATPase activity of microsomal fraction isolated from the cortical substance in the presence and absence of antibiotic alameticine and ortovandate in the incubation medium and protective action on Ca-ATPase activity of rat pretreatment with alpha-tocopherol (TP). It has been demonstrated that thermal ischemia induces inhibition of Ca-ATPase activity of microsomes resistant to vanadate. Administration of TP reduced MDA level, enhanced Ca-ATPase microsomal activity in the presence of alameticine against inhibition of enzymic activity in the absence of alameticine. This indicates a rise in the true enzyme activity under decreasing membrane permeability in conditions of diminishing activity of lipid peroxidation in response to TP effects.


Asunto(s)
Antioxidantes/uso terapéutico , ATPasas Transportadoras de Calcio/metabolismo , Calor/efectos adversos , Isquemia/tratamiento farmacológico , Isquemia/metabolismo , Corteza Renal/irrigación sanguínea , Corteza Renal/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Lípidos de la Membrana/metabolismo , Microsomas/efectos de los fármacos , Fosfolípidos/metabolismo , Vitamina E/uso terapéutico , Alameticina/farmacología , Animales , Antibacterianos/farmacología , ATPasas Transportadoras de Calcio/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Corteza Renal/metabolismo , Masculino , Microsomas/metabolismo , Ratas , Factores de Tiempo , Vanadatos/farmacología
6.
Urol Nefrol (Mosk) ; (5): 14-6, 1996.
Artículo en Ruso | MEDLINE | ID: mdl-9054096

RESUMEN

The author has estimated levels of malonic dialdehyde (MDA) indicative of activity of membrane phospholipid peroxidation activity, basal and true (in incubation in the culture containing glomeruloform antibiotic alameticin) Ca-ATPase activity in microsomal fraction isolated from cortical tissue of functioning kidneys obtained intraoperatively from 26 patients. 12 samples of cortical tissue obtained from uninvolved parts of the kidneys affected with carcinoma served as control. 14 samples were obtained from the tissue of functioning kidneys affected with nephrolithiasis and active chronic pyelonephritis. The investigations show elevated MDA levels, enhanced basal in reduced true Ca-ATPase activity of microsomes from the kidneys of patients with nephrolithiasis and active chronic pyelonephritis compared to control. It is suggested that high basal against low true Ca-ATPase activity of renal microsomes may be explained by increased permeability of renal membranes for Ca2+ under activation of lipid peroxidation in active chronic pyelonephritis and nephrolithiasis.


Asunto(s)
ATPasas Transportadoras de Calcio/metabolismo , Cálculos Renales/metabolismo , Corteza Renal/metabolismo , Neoplasias Renales/metabolismo , Peroxidación de Lípido , Microsomas/metabolismo , Pielonefritis/metabolismo , Adolescente , Adulto , Carcinoma de Células Renales/metabolismo , Enfermedad Crónica , Humanos , Malondialdehído/metabolismo , Persona de Mediana Edad
7.
Urol Nefrol (Mosk) ; (5): 8-10, 1995.
Artículo en Ruso | MEDLINE | ID: mdl-8571492

RESUMEN

Lipid peroxidation (LPO) activity has been analyzed in homogenates and microsomes of cortical samples obtained intraoperatively from the kidneys of 33 patients. Of them, 21 patients had mild, moderate or severe pyelonephritis or nephrolithiasis. Unaffected cortical tissue from renal carcinoma patients was used as control. LPO activity was judged by basal level of malonic dialdehyde (MDA) and MDA growth in the homogenate and microsomes following initiation of ascorbate-dependent LPO. Activation of LPO was registered in patients with moderate disease with active inflammation. They also exhibited greater MDA basal levels and rapid MDA increase in response to in vitro initiation of ascorbate-dependent LPO simultaneously with attenuation of endogenous antioxidant defense. In severe pyelonephritis and nephrolithiasis with drastic deficiency of renal function LPO activity was low and nonresponsive to stimulation either by ascorbate or Fe+2. This is probably due to lack of the substrate after massive death of renal cells. Enhancement of LPO activity in patients with pyelonephritis or nephrolithiasis against functioning kidneys may appear responsible for destruction of renal tissue.


Asunto(s)
Cálculos Renales/metabolismo , Corteza Renal/metabolismo , Peroxidación de Lípido , Pielonefritis/metabolismo , Adolescente , Adulto , Biopsia , Carcinoma de Células Renales/metabolismo , Enfermedad Crónica , Humanos , Corteza Renal/patología , Neoplasias Renales/metabolismo , Malondialdehído/metabolismo , Lípidos de la Membrana/metabolismo , Persona de Mediana Edad
8.
Urol Nefrol (Mosk) ; (2): 19-22, 1994.
Artículo en Ruso | MEDLINE | ID: mdl-8016998

RESUMEN

The contribution of pyelonephritis activity to calcium reabsorption defects was investigated in 176 patients with chronic pyelonephritis (CP) aged 18-54 with normal tubular filtration and calcium serum concentrations under calcium reabsorption above 98%. 86 of these patients had CP complicated by nonocclusive pelvic stones. Ca-excretory capacity of the kidneys was evaluated with estimation of the excreted calcium by activity phases considering individual deviations or without them. Measurements were also made of CP activity and severity by the inhibition of Ca-ATPase activity of the microsomes isolated from rat intact kidneys. The findings indicate that in active CP calcium-reabsorption impairments related to the inflammation are combined with the preexisting ones, the changes being more pronounced with growing activity of the inflammation, irrespective of the presence of nephrolithiasis. The relationship established between the shifts in excreted calcium induced by inflammation and plasma ability of CP patients to inhibit Ca-ATPase activity of rat renal microsomes in single tests in the same patients allows assessment of calcium reabsorption changes due to CP activity in patients when analysing their blood inhibitory effect on the test enzyme system. Simultaneous one-stage determination in CP patients of their blood inhibition in response to the test enzyme system and excreted calcium helps prognosticate calcium reabsorption expected in remission.


Asunto(s)
ATPasas Transportadoras de Calcio/antagonistas & inhibidores , Calcio/metabolismo , Pruebas Enzimáticas Clínicas , Túbulos Renales/fisiopatología , Riñón/metabolismo , Pielonefritis/diagnóstico , Absorción , Adolescente , Adulto , ATPasas Transportadoras de Calcio/metabolismo , Enfermedad Crónica , Humanos , Cálculos Renales/diagnóstico , Cálculos Renales/fisiopatología , Persona de Mediana Edad , Pronóstico , Pielonefritis/fisiopatología
9.
Urol Nefrol (Mosk) ; (1): 23-5, 1994.
Artículo en Ruso | MEDLINE | ID: mdl-8203066

RESUMEN

Whether blood plasma from 63 pyelonephritis patients can inhibit Ca-ATPase activity when compared to known toxicity marker (middle-sized molecule number) was studied. This was done to assess diagnostic potentialities of the test based on the ability of plasma from pyelonephritis patients to inhibit the test enzymatic system, i. e. Ca-ATPase activity of the microsome fraction from renal cortex in intact rats. The inhibition of Ca-ATPase activity by the plasma is shown to correlate with inflammation activity and the patients condition. In pyodestructive acute pyelonephritis this inhibition reached 60.6 +/- 3.86%, in acute serous pyelonephritis 36.02 +/- 1.54%. It follows, that the above parameter is more informative than the number of middle-sized molecules and can be introduced as one of the criteria of the patients' condition and for choice of treatment.


Asunto(s)
ATPasas Transportadoras de Calcio/antagonistas & inhibidores , Inhibidores Enzimáticos/sangre , Corteza Renal/enzimología , Microsomas/enzimología , Pielonefritis/sangre , Enfermedad Aguda , Animales , Enfermedad Crónica , Enuresis/sangre , Humanos , Masculino , Peso Molecular , Péptidos/sangre , Pielonefritis/diagnóstico , Ratas , Índice de Severidad de la Enfermedad
10.
Urol Nefrol (Mosk) ; (4): 50-5, 1989.
Artículo en Ruso | MEDLINE | ID: mdl-2800079

RESUMEN

Lipid peroxidation (LPO) was investigated in cortical layer homogenates from 56 rat kidneys, intact or exposed to a 30-minute heat ischemia performed without any protection or after a preliminary administration of prednisolone alone or in combination with methypred. Prednisolone was administered i.m. in a dose of 30 mg/kg 2 hrs before and the same dosage of methypred a day before the onset of the experiment. Homogenates were studied both for the initial levels of malonic dialdehyde (MDA) and for the MDA formation in the presence of LPO which was activated in the phosphate buffer by pH 6.8 ascorbate (5.10(-4) M) 5, 10, 15, 20, 25 and 30 minutes after the incubation. The results obtained demonstrated that versus the intact kidneys, in the kidneys exposed to a 30-minute treatment with heat ischemia there were increased levels of initial MDA in the renal tissue, a dramatic increment of its formation during the incubation of homogenate with ascorbate. Shifts in the kinetic curves in homogenates from ischemic kidneys were noted as well. A more dramatic rise (versus intact kidneys) in the MDA formation levels in the presence of LPO observed at the initial stage of the incubation was suggestive of an exhaustive effect of heat ischemia on the system of endogenous antioxidants. The dramatic increment of MDA levels was recorded during a 30-minute incubation. Administration of prednisolone alone or in combination with methypred resulted in a significant inhibition of LPO in ischemic renal tissue.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Glucocorticoides/uso terapéutico , Calor/efectos adversos , Isquemia/metabolismo , Corteza Renal/metabolismo , Riñón/irrigación sanguínea , Peroxidación de Lípido/efectos de los fármacos , Animales , Isquemia/tratamiento farmacológico , Isquemia/etiología , Corteza Renal/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Ratas , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...